The fourth shot of the COVID-19 vaccine can boost antibodies but provides insufficient protection against the Omicron variant, a new study has shown.
Early studies had suggested that two or three doses of COVID-19 vaccines may not be as effective against the Omicron variant.
Albert Bourla, Pfi
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
